DOSSIER · 13F Holders · Q2 2026

ENLIVEX THERAPEUTICS LTD

14 institutions still hold ENLIVEX THERAPEUTICS LTD as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP M4130Y106·14 13F holders·last filed Jun 30, 2026
Market cap
—
13F value held
$640K
visible holders
Holders
14
filers reporting
Concentration
27.62%
PRELUDE CAPITAL MANAGEMENT, LLC #1
top holder share
AI Holders Summary · Q2 2026

14 institutions reported ENLIVEX THERAPEUTICS LTD in Q2 2026. PRELUDE CAPITAL MANAGEMENT, LLC leads at 27.6% of the visible book.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
PRELUDE CAPITAL MANAGEMENT, LLC
CIK 0001387508
$177K321K0.01%Q2 2026
02
BANK OF AMERICA CORP /DE/
CIK 0000070858
$106K193K0.00%Q2 2026
03
TWO SIGMA INVESTMENTS, LP
CIK 0001179392
$101K184K0.00%Q2 2026
04
SUSQUEHANNA INTERNATIONAL GROUP, LLP
CIK 0001446194· Market maker
$87K158K0.00%Q2 2026
05
GOLDMAN SACHS GROUP INC
CIK 0000886982
$49K89K0.00%Q2 2026
06
CITADEL ADVISORS LLC
CIK 0001423053
$49K88K0.00%Q2 2026
07
Virtu Financial LLC
CIK 0001533964· Market maker
$40K43K0.00%Q1 2026
08
XTX Topco Ltd
CIK 0001828301
$12K22K0.00%Q2 2026
09
SkyView Investment Advisors, LLC
CIK 0001848237
$9K10K0.00%Q1 2026
10
Chico Wealth RIA
CIK 0001926037
$9K16K0.00%Q2 2026
11
MCGUIRE CAPITAL ADVISORS INC
CIK 0002112006
$1K3K0.00%Q2 2026
12
Red Tortoise LLC
CIK 0001910488
$1401500.00%Q1 2026
13
WELLS FARGO & COMPANY/MN
CIK 0000072971
$1102000.00%Q2 2026
14
CONCOURSE FINANCIAL GROUP SECURITIES, INC.
CIK 0000752798
$00—Q2 2025